Acura Pharmaceuticals Shares Surge On Drug Approval

by Monica Gerson, Benzinga Staff Writer
June 20, 2011 8:47 AM | 19 seconds read |
Shares of Acura Pharmaceuticals Inc ACUR surged about 65% in pre-market trading after the company announced that the US Food and Drug Administration (FDA) had approved a tamper-resistant pain drug owned by Acura and Pfizer Inc PFE. ACUR shares gained 65.37% to $6.40 in pre-market trading. Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDAPre-Market OutlookMarketsMoversHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!